Clear Creek Financial Management, LLC Athira Pharma, Inc. Transaction History

Clear Creek Financial Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 24, 2022	SELL	$2.93 - $3.96 $9,595 - $12,969	-3,275 Reduced 24.67%	10,000 $30,000
Q2 2022 Jul 27, 2022	SELL	$2.74 - $13.43 $3,288 - $16,116	-1,200 Reduced 8.29%	13,275 $40,000
Q1 2022 May 02, 2022	BUY	$8.96 - $13.51 $448 - $675	50 Added 0.35%	14,475 $195,000
Q4 2021 Jan 21, 2022	SELL	$9.17 - $16.39 $3,438 - $6,146	-375 Reduced 2.53%	14,425 $188,000
Q3 2021 Oct 14, 2021	SELL	$9.15 - $11.09 $1,830 - $2,218	-200 Reduced 1.33%	14,800 $139,000
Q2 2021 Jul 30, 2021	BUY	$10.24 - $20.87 $153,600 - $313,050	15,000 New	15,000 $154,000

16.8M

112K

68K

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $18.9M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

Get notified when there are updates to the investment portfolio of Clear Creek Financial Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Clear Creek Financial Management, LLC with notifications on news.